Capnopharm to acquire operational assets of Capnomed
Capnomed successfully introduced the medical device Capnopen, the gold standard of laparoscopic nebulizers.
Capnomed successfully introduced the medical device Capnopen, the gold standard of laparoscopic nebulizers.
It includes both public and private health facilities including hospitals, clinics, diagnostic laboratories, and imaging centers
The new facility will be delivered through an investment of approximately CHF 500 million and is expected to be completed in 2026
Company is investing more than €100 million in the expansion of the Halle site
Merck is organizing one of the biggest South APAC Virtual Conclave on ‘Next-Gen Labs’ on 20th July.
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
The AICVD tool can predict the risk of cardiovascular disease.
Vaccizone’s ASC Technology is an enhanced antigen/bioactive delivery method based on Antigen Presenting Cells
Younger Indians have a 10 times higher rate of heart attack
Subscribe To Our Newsletter & Stay Updated